Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Imazawa, T.
Right arrow Articles by Hirose, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imazawa, T.
Right arrow Articles by Hirose, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCAGON
Medline Plus Health Information
*Pancreatic Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Induction of Pancreatic Islet Cell Tumors in Rats by Repeated Intravenous Administration of 4-hydroxyaminoquinoline 1-oxide

Takayoshi Imazawa

Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan, imazawa{at}nihs.go.jp

Akiyoshi Nishikawa

Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan

Makoto Shibutani

Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan

Hiroyuki Ogasawara

Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan

Fumio Furukawa

Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan

Takako Ikeda

Showa Women's University, 1-7 Taishido, Setagaya-ku, Tokyo 158-8533, Japan

Koichi Suda

Department of Pathology, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

Masao Hirose

Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan

The inducibility of pancreatic islet cell tumors by administration of 4-hydroxyaminoquinolin e 1-oxide (4HAQO) was investigated in male 6-week-old Sprague—Dawley rats. Rats were given 4HAQO intravenously at a weekly dose of 5 mg/kg 4 times (group 1) or a single dose of 10 mg/kg (group 2). Control rats received the vehicle alone (group 3). Fifty-six weeks after the first 4HAQO administration, all surviving animals were killed and the pancreas was examined histopathologically, immunohistochemically and ultrastructurally. The incidences and multiplicities of islet cell tumors in groups 1, 2, and 3 were 52.3% (p < 0.05 vs group 2, p < 0.01 vs group 3), 19.2% and 0%, and 0.70/animal (p < 0.05 vs group 2, p < 0.01 vs group 3), 0.23 and 0, respectively. Islet cell carcinomas were induced only in group 1, accounting for 6/44 (26%) tumors. Islet cell hyperplasias were found in 61.4% (p < 0.05 vs group 3), 42.3% and 10.0% of groups 1, 2, and 3, with multiplicities of 0.95 ( p < 0.05 vs groups 2 and 3), 0.54 and 0.20, respectively. As compared with normal islets from control subjects, islet cell tumors showed an increase in the number of insulin positive cells associated with cytological features indicative of enhanced insulin synthesis and secretion, and a decrease in the number of glucagon positive cells without ultrastructural signs of modified secretory activity. Thus our results indicate that repeated intravenous administration of 4HAQO to rats is useful for the induction of islet cell tumors at high incidence.

Key Words: Immunohistochemistry • islet cell tumors • rat • 4HAQO

References

  • Bencosme SA, Allen RA, Latta H. (1963). Functioning pancreatic islet cell tumors studied electron microscopically. Am J Pathol 42: 1—10.[Medline] [Order article via Infotrieve]
  • Berger M., Bordi C., Cuppers HJ, Berchtold P., Gries FA, Munterfering H., Sailer R., Zimmerman H., Orci L. ( 1983). Functional and morphological characterrization of human insulinomas. Diabetes 32: 921—931.[Abstract]
  • Creutzfeldt W., Arnold R., Creutzfeldt C., Deutiche U. (1973). Biochemical and morphological investigations of 30 human insulinomas. Correlations between tumor content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia 9: 213—231.
  • Denda A., Mori Y., Yokose Y., Uchida K., Murata Y., Makino T., Tsutsumi M., Konishi Y. (1985). 4-Hydroxyaminoquinolin e 1-oxide metabolism and DNA adducts in the early stage of tumorigenesis in rats: Comparison of target organ pancreas with non-target organ liver. Chem Biol Interact 56: 125—143.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Dillberger JE (1994). Age-related pancreatic islet changes in Sprague— Dawley rats. Toxicol Pathol 22: 48—55.[Abstract/Free Full Text]
  • Greider MH, Elliott DW (1964). Electron microscopy of human pancreatic tumors of islet cell origin. Am J Pathol 44: 663—678.[Web of Science][Medline] [Order article via Infotrieve]
  • Hayashi Y., Hasegawa T. (1971). Experimental pancreatic tumors in rats after intravenous injection of 4-hydroxyaminoquinolin e 1-oxide. Gann 62: 329—330.[Web of Science][Medline] [Order article via Infotrieve]
  • Hayashi Y., Furukawa H., Hasegawa T. (1972). Pancreatic tumors in rats induced by 4-nitroquinoline 1-oxide derivatives. In: Topics in Chemical Carcinogenesis, Nakahara W, Takayama S, Sugimura T, Odashima S (eds). University Park Press, Baltimore, pp 53—72.
  • Hozumi M. (1969). Induction of skin tumors in mice by painting with 4-hydroxyaminoquinoline 1-oxide. Gann 60: 161—165.[Web of Science][Medline] [Order article via Infotrieve]
  • Ikenaga M., Ishii Y., Tada M., Kakunaga T., Takeda H., Kondo S. (1975). Excision-repair of 4-nitroquinoline 1-oxide damage responsible for killing, mutation and cancer. In: Molecular Mechanisms for Repair of DNA, Hanawalt PC, Setlow RB (eds). Plenum Press, New York, pp 763—771.
  • Imazawa T., Nishikawa A., Tada M., Takahashi M., Hayashi Y. (1995). Nucleolar segregation as an early marker for DNA damage; an experimental study in rats treated with 4-hydroxyaminoquinoline 1-oxide. Virchows Archiv 426: 295—300.[Web of Science][Medline] [Order article via Infotrieve]
  • Imazawa T., Nishikawa A., Todate A., Furukawa F., Onodera H., Mitsumori K., Hirose M., Hayashi Y. (2000). Dual effects of prolonged ACTH stimulation on 4-hydroxyaminoquinolin e 1-oxide-induced adrenalcortical lesions in rats. Toxicol Pathol 28: 535—539.[Abstract/Free Full Text]
  • Konishi Y., Denda A., Inui S., Takahashi S., Kondo H. (1976). Pancreatic carcinoma induced 4-hydroxyaminoquinolin e 1-oxide after partial pancreatectomy and splenectomy in rats. Gann 67: 919—920.[Web of Science][Medline] [Order article via Infotrieve]
  • Konishi Y., Maruyama H., Mii Y., Miyauchi Y., Yokose Y., Masuhara K. (1982). Malignant fibrous histocytomas induced by 4-hydroxyaminoquinolin e 1-oxide in rats. J Natl Cancer Inst 68: 859—865.[Web of Science][Medline] [Order article via Infotrieve]
  • Kunz J., Amendt P., Buntrock P., Gottschalk J., Dorsche Hahn von (1986). Pancreatic endocrine tumours: Histological, immunocytochemical and elektronmicroscopical investigations. Acta Histochem Suppl Band XXXIII, S: 233—241.
  • Miller EC (1978). Some current perspectives on chemical carcinogenesi s in humans and experimental animals: Presidental address. Cancer Res 38: 1479—1496.[Free Full Text]
  • Milman HA, Ward JM, Chu KC (1978). Pancreatic carcinogenesi s and naturally occuring pancreatic neoplasms of rats and mice in the NCI Carcinogenesis Testing Program. J Environ Pathol Toxicol 1, 829—840.
  • Mori K., Kondo M., Koibuchi E., Hashimoto A. (1976). Induction of lung cancer in mice by injection of 4-hydroxyaminoquinolin e 1-oxide. Gann 58: 105—106.
  • Mori K., Ohta A., Murakami T., Tamura M., Kondo M., Ichimura H. (1969). Carcinomas of the glandular stomach and other organs of rats by 4-hydroxyaminoquinolin e 1-oxide hydrochloride. Gann 60: 627—630.[Web of Science][Medline] [Order article via Infotrieve]
  • Morohoshi T., Kanda M., Klö ppel G. (1984). On the histogenesis of experimental pancreatic endocrine tumors. An immunocytochemica l and electron microscopical study. Acta Pathol Jpn 34: 271—281.[Medline] [Order article via Infotrieve]
  • Nagao M., Sugimura T. (1976). Molecular biology of the carcinogen 4-nitroquinoline 1-oxide. Adv Cancer Res 23: 132—169.
  • Qin X., Nakatsuru Y., Tada M., Ishikawa T. (1990). Species and differences in DNA adduct formation and repair after treatment with 4-hydroxyaminoquinoline 1-oxide. Jpn J Cancer Res 81: 613—619.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rao MS, Upton MP, Subbarao V., Scarpelli DG (1982). Two populations of cells with differing proliferative capacities in atypical acinar cell foci induced by 4-hydroxyaminoquinoline 1-oxide in the rat pancreas. Lab Invest 46: 527—534.[Web of Science][Medline] [Order article via Infotrieve]
  • Riley MGI, Boorman GA, Hayashi Y. (1990). Endocrine pancreas. In: Pathology of the Fischer Rat, Boorman GA, Eustis SL, Elwell MR, Montgomery CA Jr, Mackenzie WE (eds). Academic Press, San Diego, pp 545—553.
  • Rowlatt U., Roe FJC (1967). Epithelial tumors of the rat pancreas. J Natl Cancer Inst 39: 18—32.
  • Schoental R., Fowler ME, Coady A. (1970). Islet cell tumors of the pancreas found in rats given pyrrolizidine alkaloids from Amsinckia intermedia Fish and Mey and from Helicotropium supinum L. Cancer Res 30: 2127—2131.[Abstract/Free Full Text]
  • Shinozuka H., Popp JA, Konishi Y. (1976). Ultrastructure of atypical acinar cell nodules in rat pancreas induced by 4-hydroxyaminoquinoline 1-oxide. Lab Invest 34: 501—509.[Web of Science][Medline] [Order article via Infotrieve]
  • Shurgin A., Becker FF (1974). Sequential events in induction of sarcomas by 4-hydroxyaminoquinoline 1-oxide: Fibroplasia, a premalignant phase. J Natl Cancer Inst 53: 159—164.[Web of Science][Medline] [Order article via Infotrieve]
  • Solcia E., Capella C., Klö ppel G. (1997). Atlas of pathology; Tumors of the pancreas. In: Tumors of the endocrine pancreas, Rosai J, Sobin LH (eds). Armed Forces Institute of Pathology, Washington, DC, pp 145— 208.
  • Sugimura T. (1981). The nitroquinolines. In: Carcinogenesis. A Comprehensive Survey, Vol. 6, Raven Press, New York, pp 1—159.
  • Suzuki H., Matsuyama M. (1971). Ultrastructure of functioning beta cell tumors of the pancreatic islets. Cancer 28: 1302—1313.[Medline] [Order article via Infotrieve]
  • Toker C. (1967). Observations on the ultrastructure of a metastasizing beta cell islet cell tumor. Diabetes 16: 800—803.[Medline] [Order article via Infotrieve]
  • Wilson GL, LeDoux SP (1989). The role of chemicals in the etiology of diabetes mellitus. Toxicol Pathol 17: 357—363.[Web of Science][Medline] [Order article via Infotrieve]
  • Yagihashi S., Nagai K. (1981). Immunohistochemical and ultrastructural studies on rat islet tumors induced by streptozotocin and nicotinamide. Virchows Arch [Pathol Anat] 390: 181—191.[Medline] [Order article via Infotrieve]
  • Yamagami T., Miwa A., Takasawa S., Yamamoto H., Okamoto H. (1985). Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly (adenosine disphosphate ribose) synthetase inhibitors. Cancer Res 45: 1845—1849.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 29, No. 3, 320-327 (2001)
DOI: 10.1080/019262301316905273


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
T. Imazawa, A. Nishikawa, K. Toyoda, F. Furukawa, M. Mitsui, and M. Hirose
Sequential Alteration of Apoptosis, p53 Expression, and Cell Proliferation in the Rat Pancreas Treated with 4-Hydroxyaminoquinoline 1-Oxide
Toxicol Pathol, October 1, 2003; 31(6): 625 - 631.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Imazawa, T.
Right arrow Articles by Hirose, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imazawa, T.
Right arrow Articles by Hirose, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCAGON
Medline Plus Health Information
*Pancreatic Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?